Ondansetron Tablet, Orally Disintegrating
Product Images NDC 57237-078

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 57237-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30 Tablets Bottle))

This is a product description for Rising® Noc57237-077-30, which contains 30 orally disintegrating tablets of Ondansetron USP 4 mg each. It contains phenylalanine and should be stored at 20" to 25°C. The product meets USP Disintegration Test 2 and should not be removed from the bottle until immediately before use. Dosage instructions can be found in the package insert. It comes in a tight, light-resistant container and is distributed by Rising Heath, LLC. The product is made in India and has a code of TS/DRUGS/18/1883 with a revised date of 04/2018.*

FDA Label Image

Package Label-principal Display Panel (4 mg Blister Carton (3 x 10 Unit-dose))

This is the product label for Rising's Ondansetron Orally Disintegrating Tablets, USP. It contains the product's NDC number, ingredients, dosage form, and the number of tablets included in the package. However, there seems to be a few errors and garbled characters in the text.*

FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablets Bottle))

Rising® Noc57237-078-30 is a medication distributed in orally disintegrating tablet form, containing Ondansetron USP Ema and 3.37mg of phenylalanine per tablet. The usual dosage is described in the package insert. The tablets meet the USP Disintegration Test 2 and must be stored between 20°C and 25°C with short excursions permitted to 15°C to 30°C. They are dispensed in a tight, light-resistant bottle containing 30 tablets. Instructions on the bottle specify that the tablets should not be removed from the bottle until immediately before use.*

FDA Label Image

Package Label-principal Display Panel (8 mg Blister Carton (3 x 10 Unit-dose))

FDA Label Image

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.